about
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass SpectrometryMass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury TreatmentThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsApplications of mass spectrometry to structural analysis of marine oligosaccharides.Improvement of the digestibility of sulfated hyaluronans by bovine testicular hyaluronidase: a UV spectroscopic and mass spectrometric studyHeparan sulfate differences in rheumatoid arthritis versus healthy seraEfficient recovery of glycosaminoglycan oligosaccharides from polyacrylamide gel electrophoresis combined with mass spectrometry analysis.De Novo Sequencing of Complex Mixtures of Heparan Sulfate OligosaccharidesDe novo sequencing of heparan sulfate oligosaccharides by electron-activated dissociation.The challenge and promise of glycomics.Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling.Positive Mode LC-MS/MS Analysis of Chondroitin Sulfate Modified Glycopeptides Derived from Light and Heavy Chains of The Human Inter-α-Trypsin Inhibitor Complex.Applications of capillary electrophoresis electrospray ionization mass spectrometry in glycosaminoglycan analysis.Medical application of glycosaminoglycans: a review.Glycosaminoglycanomics: where we are.Characterization of Glycan Structures of Chondroitin Sulfate-Glycopeptides Facilitated by Sodium Ion-Pairing and Positive Mode LC-MS/MS.A computational framework for heparan sulfate sequencing using high-resolution tandem mass spectra.Structural elucidation of fucosylated chondroitin sulfates from sea cucumber using FTICR-MS/MS.Isomer separation and effect of the degree of polymerization on the gas-phase structure of chondroitin sulfate oligosaccharides analyzed by ion mobility and tandem mass spectrometry.In vitro anti-thrombotic and anti-coagulant properties of blacklip abalone (Haliotis rubra) viscera hydrolysate.Negative Electron Transfer Dissociation Sequencing of 3-O-Sulfation-Containing Heparan Sulfate Oligosaccharides.
P2860
Q27024150-80E10671-9E2F-45C1-BB56-11B48ADC94D9Q28395356-905C8F74-5E30-4720-B187-E12C80F58D63Q33851544-B7D22376-C73D-4843-9250-C0ADF3D9E795Q33963549-51D9242B-3205-44D3-A8FA-4B0AE9A3049FQ35196193-3204F12F-F85C-4CB2-BA55-E1A0BC15CCFDQ35531571-C21D06D5-A451-4877-B54B-B6E3275E62B3Q36188988-9537A80C-D25E-4672-B4E3-4D6AFC4B872FQ37347421-6A83D755-0834-4F62-9066-3844896BDD65Q37551741-3EFCE4EA-FF5A-42C0-B159-28E4DB8BA44CQ37638949-B72B50AC-20A0-4E9F-9DB2-3C1D5D4F5B2EQ38303432-FEBE268C-D04C-4E14-B930-3D3DD303D0C5Q38588372-0BB5DEE3-9087-4055-A77C-206B064ACA66Q38678456-85A7FBF3-C4D8-4E9B-85A7-37E943F22EBBQ39083233-8EB38BBF-3159-4080-9178-F40C1CA281EDQ39143849-F6F3E360-45EB-4F69-BD3A-8DBBFA3759DDQ41303602-7DE0BC72-ED7E-4C61-AB9A-99E84A3779DCQ41998384-AA7B0F84-7A89-45C9-9DD2-576748A76A14Q46242830-390D37B2-81CE-45D6-8034-038704099584Q46307907-C2147852-2DAA-4FA2-9AA0-917A6D2F2449Q50656479-01D4B592-4213-471A-8848-7CB15CA84AC5Q52346784-94DD4D27-9BDD-4E81-B9E4-FA4447D07B9C
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Glycosaminoglycan glycomics using mass spectrometry
@ast
Glycosaminoglycan glycomics using mass spectrometry
@en
Glycosaminoglycan glycomics using mass spectrometry
@nl
type
label
Glycosaminoglycan glycomics using mass spectrometry
@ast
Glycosaminoglycan glycomics using mass spectrometry
@en
Glycosaminoglycan glycomics using mass spectrometry
@nl
prefLabel
Glycosaminoglycan glycomics using mass spectrometry
@ast
Glycosaminoglycan glycomics using mass spectrometry
@en
Glycosaminoglycan glycomics using mass spectrometry
@nl
P2860
P356
P1476
Glycosaminoglycan glycomics using mass spectrometry
@en
P2093
P2860
P304
P356
10.1074/MCP.R112.026294
P407
P577
2013-04-01T00:00:00Z